Lipid-lowering, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease: a randomized, double-blinded, placebo-controlled trial

HIGHLIGHTS

• What: The aim of this randomized, double-blinded, placebo-controlled trial was to investigate whether supplementation with NK and RYR can alter cardiometabolic parameters in patients with CAD and whether the combination will be superior to NK or RYR alone, as well as to examine the safety and cardiometabolic responses when co-administer with heart medications. The indication of favorable LDH and CK changes in CAD patients first seen in this study reveals the exciting potential of the effects of NK and RYR in preventing acute cardiovascular events, aside from most studied longer-term lipid and blood . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.